Principal Securities, Inc. Bio N Tech Se Transaction History
Principal Securities, Inc.
- $3.63 Trillion
- Q2 2024
A detailed history of Principal Securities, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Principal Securities, Inc. holds 150 shares of BNTX stock, worth $18,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 154
2.6%
Holding current value
$18,510
Previous $14.2 Million
15.15%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$1.02 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$591 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$540 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$361 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$234 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...